Fund Advisors of America »

Recursion Pharmaceuticals shares owned by Fund Advisors of America

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Fund Advisors of America from 13F filings

Historical chart of Fund Advisors of America investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Fund Advisors of America consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Fund Advisors of America

Quarter filed Position value Share count Share price at filing
2025-12-31 $82k 20k 4.09

More positions owned by Fund Advisors of America

NVIDIA Corporation (NVDA)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Main Street Capital Corporation (MAIN)
International Business Machines (IBM)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Etfis Ser Tr I Virtus Infrcap (PFFA)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Marvell Technology (MRVL)
Fs Credit Opportunities Corp Common Stock (FSCO)
Vaneck Etf Trust Gold Miners Etf (GDX)
Spdr Gold Tr Gold Shs (GLD)
Cloudflare Cl A Com (NET)

View all positions for Fund Advisors of America

Top funds holding Recursion Pharmaceuticals

Vanguard Group
BlackRock
ARK Investment Management
State Street Corporation
Baillie Gifford & Co
Softbank Group Corp
Kinnevik AB
Geode Capital Management
MIC Capital Management UK
Susquehanna International
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Data Collective IV GP
Norges Bank Investment Management
Exor Investments

View all funds holding Recursion Pharmaceuticals